Helen Torley, PRESIDENT AND CEO at HALOZYME THERAPEUTICS, INC. (HALO), sold 40,000 shares at $43.26 ($1.7M) on 2023-03-08, disclosed to the SEC on 2023-03-09.
Open-market sale of $1.7M HALO by PRESIDENT AND CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.47 | 10,000 | $455K | 26.1% |
| 2 | $43.26 | 10,000 | $433K | 24.8% |
| 3 | $42.73 | 10,000 | $427K | 24.5% |
| 4 | $42.73 | 10,000 | $427K | 24.5% |
| Total | $43.55 avg | 40,000 | $1.7M | 100% |
| Filing → |
| HALO | SELL | 2026-07-09 | $153K | — | Filing → |
| HALO | SELL | 2026-06-03 | $3.4M | — | Filing → |
| HALO | SELL | 2026-05-13 | $3.4M | — | Filing → |